Please login to the form below
Russell Reynolds Associates
This page shows the latest Russell Reynolds Associates news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
Dispensing with the past
Recent global research undertaken by Russell Reynolds Associates (RRA) examines the questions of whether the board leadership of pharma companies is in the best position to face current and future challenges ... Christopher Burrows, a senior partner in
-
Healthcare and the digital revolution
industries. Ernest Brittingham is a senior member of the global medical devices and diagnostics practice and Nanaz Mohtashami is a member of the healthcare sector at Russell Reynolds Associates. ... Ernest Brittingham is a senior member of the global
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Wave adds programme manager to team
A graduate of Oxford Brookes University, Hopkins has also had spells as McCann Complete Medical and Russell Reynolds Associates in addition to a period as a research scientist at Green Biologics.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Account Director, Medical Education
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Copywriter
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Roche reports continued growth in Q3, despite biosimilar competition
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- Vertex scores FDA approval for CF triple therapy Trikafta
- Seattle Genetics preps filing next year for oral HER2 drug
- Novartis grows in Q3 thanks to stellar performance of key drugs
- AZ’s Farxiga gets heart failure prevention okay from FDA
- Evolution or revolution: the latest review of NICE methods
- Merck KGaA launches €13m seed fund for Chinese startups
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- Evolution or revolution: the latest review of NICE methods
- By Leela Barham...
- Integrating patient reported outcomes into clinical trials
- How capturing the patient voice is unlocking medicines’ commercial potential...
- A snapshot of Crescendo Biologics
- PME talks to CEO Theodora Harold...
Quick links
Infographics
